SCHEMBL17640528

SCHEMBL17640528

CC1(C)c2ccccc2N(c2ccc(-c3noc(-c4ccc(F)cc4)n3)cc2)c2ccccc21

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 6/20 0.50
▸ RAB9A P51151 6/20 0.50
▸ SMN1; SMN2 Q16637 4/20 0.50
▸ TP53 P04637 1/20 0.50
▸ NFKB1 P19838 3/20 0.44
▸ NFKB2 Q00653 3/20 0.44
▸ RELA Q04206 3/20 0.44
▸ NR1H4 Q96RI1 3/20 0.43
▸ ATM Q13315 1/20 0.42
▸ CASP3 P42574 2/20 0.41
▸ SENP8 Q96LD8 2/20 0.41
▸ SENP7 Q9BQF6 2/20 0.41
▸ SENP6 Q9GZR1 1/20 0.41
▸ S1PR1 P21453 2/20 0.41
▸ ALDH1A1 P00352 3/20 0.41
▸ HSD17B10 Q99714 2/20 0.41
▸ HPGD P15428 1/20 0.41
▸ CXCR1 P25024 1/20 0.40
▸ MAPT P10636 3/20 0.40
▸ MEN1 O00255 3/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19499744 0.94 NPC1 (0.49) NPC1RAB9ASMN1; SMN2TP53NFKB1
SCHEMBL17640554 0.91 NR1H4 (0.54) NPC1RAB9ASMN1; SMN2TP53NFKB1
SCHEMBL17640539 0.91 NR1H4 (0.54) NPC1RAB9ASMN1; SMN2TP53NFKB1
SCHEMBL19499750 0.89 NPC1 (0.58) NPC1RAB9ASMN1; SMN2TP53NFKB1
SCHEMBL17640623 0.88 NPC1 (0.44) NPC1RAB9ASMN1; SMN2TP53NFKB1
SCHEMBL17640532 0.82 NPC1 (0.53) NPC1RAB9ASMN1; SMN2TP53NFKB1
SCHEMBL17640600 0.81 S1PR1 (0.47) NPC1RAB9ASMN1; SMN2TP53NFKB1
SCHEMBL17640622 0.80 BCHE (0.38) NPC1RAB9ASMN1; SMN2TP53NFKB1
SCHEMBL17640555 0.79 NR1H4 (0.50) NPC1RAB9ASMN1; SMN2TP53NFKB1
SCHEMBL17278593 0.79 KMT2A (0.36) ALDH1A1HPGDMAPTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10333078-B2 Fluorescent organic light emitting elements having high efficiency UDC IRELAND LIMITED (IE) 2019-06-25 — — US disclosed
US-20170309828-A1 Fluorescent Organic Light Emitting Elements Having High Efficiency BASF SE (DE) 2017-10-26 — — US disclosed
US-20170309828-A1 Fluorescent Organic Light Emitting Elements Having High Efficiency BASF SE (DE) 2017-10-26 — — US disclosed
WO-2016046350-A1 FLUORESCENT ORGANIC LIGHT EMITTING ELEMENTS HAVING HIGH EFFICIENCY BASF SE (DE) 2016-03-31 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10333078-B2 Fluorescent organic light emitting elements having high efficiency NR2E3, CRY1, ALDH1A2 NPC1 4857/4885RAB9A 4709/4885SMN1; SMN2 3296/4885
US-20170309828-A1 Fluorescent Organic Light Emitting Elements Having High Efficiency NR2E3, CRY1, ALDH1A2 NPC1 4857/4885RAB9A 4709/4885SMN1; SMN2 3296/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback